| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,253,113 | 1,106,398 | 722,180 | 986,166 | | Cost of Revenue | 1,229,386 | 1,059,663 | 608,594 | 886,322 | | | Gross Profit | 23,727 | 46,735 | 113,586 | 99,844 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,276 | 31,581 | 31,915 | (9,713) | | Non Recurring | (1,600) | 1,600 |
-
| (50,385) | | Others | 25,247 | 23,561 | 22,090 | 22,270 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (34,343) | (10,007) | 59,581 | 137,672 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,777) | 191 | 257 | 407 | | Earnings Before Interest And Taxes | (45,043) | (1,440) | 59,835 | 138,864 | | Interest Expense | 21,460 | 21,023 | 28,256 | 24,665 | | Income Before Tax | (66,503) | (22,463) | 31,579 | 114,199 | | Income Tax Expense | (16,452) | (7,549) | 10,995 | 46,931 | | Minority Interest |
-
| 3,233 | (3,233) | (6,331) | | | | Net Income From Continuing Ops | (9,033) | (11,681) | 17,351 | 60,937 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,033) | (11,681) | 17,351 | 60,937 | | Preferred Stock And Other Adjustments |
-
| (3,659) |
-
|
-
| | | Net Income Applicable To Common Shares | ($26,558) | ($15,340) | $17,351 | $60,937 |
|
0.04% Nasdaq 
0.34%
Income Statement
